Skip to main content

Table 2 Resistance rate of different isolates from inpatient and outpatient settings

From: A retrospective analysis of the etiologic agents and antibiotic susceptibility pattern of uropathogens isolated in the Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan

Isolates

Antibiotics

AMX

CZO

CRO

NAL

NOR

SXT

GEN

NIT

CTX

VAN

PEN

ERY

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

IN

OUT

E. coli (n* = 91/594)

75.8

67.1

54.9

37.8

36.2

20.7

85.7

74.9

51.6

37.7

62.6

54.2

19.7

15.4

4.3

2.6

31.8

18.1

K. pneumonia (n* = 6/30)

66.6

30

66.6

10

33.3

20

16.6

13.3

50

26.6

50

3.3

16.6

10

50

10

Enterococcus spp. (n* = 9/14)

55.5

14.2

33.3

50

0

14.2

0

7.1

0

0

100

57.1

88.8

57.1

S. saprophyticus (n* = 4/16)

25

0

0

6.2

0

6.2

25

12.5

25

0

25

0

75

62.5

0

0

Acinetobacter spp. (n* = 4/14)

50

35.7

100

64.2

25

7.1

25

14.2

25

7.1

50

14.2

75

78.5

25

7.1

Proteus spp. (n* = 4/19)

0

63.1

0

89.4

0

0

0

31.5

0

10.5

25

31.5

0

10.5

0

0

K. oxytoca (n* = 3/7)

0

28.5

0

100

0

42.8

0

57.1

0

42.8

0

28.5

0

28.5

0

0

0

42.8

Citrobacter spp. (n*=1/8)

0

100

0

87.5

0

25

0

12.5

0

12.5

0

12.5

0

12.5

0

12.5

0

25

S. aureus (n*=1/6)

0

33.3

0

0

100

83.3

0

16.6

Enterobacter spp. (n*=1/7)

0

71.4

0

71.4

0

14.2

0

14.2

0

14.2

0

0

0

28.5

0

14.2

  1. n* inpatient/outpatient, IN inpatient, OUT outpatient, AMX amoxicillin, CZO cefazolin, CRO ceftriaxone, NAL nalidixic acid, NOR norfloxacin, SXT cotrimoxazole, GEN gentamicin, NIT nitrofurantoin, CTX cefotaxime, VAN vancomycin, PEN penicillin, ERY erythromycin